You are here:

AstraZeneca UK Ltd

Name SMC ID No Status Sub. Type
 
Anastrozole (Arimidex®) 90/04 Restricted Full submission
anastrozole 1mg tablet (Arimidex) 322/06 Restricted Full submission
Anastrozole 1mg tablets (Arimidex®) 198/05 Restricted Full submission
budesonide (Pulmicort) 536/09 Accepted Abbreviated Submission
budesonide-formoterol (Symbicort SMART) 1244/17 Accepted Abbreviated Submission
budesonide-formoterol (Symbicort) 1198/16 Not Recommended Non submission
Budesonide/eformoterol (Symbicort) 97/04 Accepted Full submission
budesonide/formoterol 100/6, 200/6 turbohaler (Symbicort SMART) 362/07 Accepted Full submission
ceftaroline fosamil (Zinforo) 830/12 Restricted Full submission
dapagliflozin (Forxiga) 799/12 Restricted Resubmission
dapagliflozin (Forxiga) 799/12 Superseded Resubmission
dapagliflozin + metformin (Xigduo) 983/14 Restricted Abbreviated Submission
esomeprazole (Nexium) 422/07 Accepted Full submission
Esomeprazole (Nexium®) 257/06 Not Recommended Full submission
Esomeprazole (Nexium®) 124/04 Accepted Full submission
Esomeprazole (Nexium®) 274/06 Not Recommended Full submission
esomeprazole 20mg and 40mg tablets(Nexium) 368/07 Restricted Full submission
esomeprazole IV 40mg powder (Nexium) 578/09 Accepted Full submission
esomeprazole oral suspension (Nexium) Abbreviated 639/10 Restricted Abbreviated Submission
fulvestrant (Faslodex) 114/04 Accepted Resubmission
fulvestrant (Faslodex) 1294/17 Not Recommended Non submission
Fulvestrant (Faslodex®) 114/04 Not Recommended Full submission
gefitinib (Iressa) 615/10 Not Recommended Full submission
gefitinib (Iressa) 615/10 Not Recommended Resubmission
gefitinib (Iressa) 615/10 Restricted Resubmission
naloxegol (Moventig) 1106/15 Accepted Full submission
naproxen + esomeprazole (Vimovo) 734/11 Not Recommended Full submission
olaparib (Lynparza) 1047/15 Accepted Resubmission
olaparib (Lynparza) 1047/15 Not Recommended Full submission
osimertinib (Tagrisso) 1214/17 Restricted Full submission
quetiapine (Seroquel XL) 744/11 Not Recommended Non submission
Quetiapine (Seroquel) 104/04 Accepted Full submission
quetiapine fumerate (Seroquel XL) 433/07 Accepted Abbreviated Submission
quetiapine fumerate (Seroquel) 549/09 Not Recommended Full submission
quetiapine prolonged release and quetiapine immediate release (Seroquel XL and Seroquel IR) 549/09 Not Recommended Resubmission
roflumilast (Daxas) 635/10 Not Recommended Resubmission
rosuvastatin (Crestor) 725/11 Not Recommended Full submission
rosuvastatin (Crestor®) 45/03 Accepted Full submission
saxagliptin (Onglyza) 772/12 Not Recommended Non submission
saxagliptin (Onglyza) 772/12 Accepted Full submission
saxagliptin/dapagliflozin fixed dose combination (Qtern) 1255/17 Restricted Abbreviated Submission
ticagrelor (Brilique) 699/11 Accepted Full submission
ticagrelor (Brilique) 1224/17 Not Recommended Full submission
vandetanib (Caprelsa) 797/12 Not Recommended Non submission

Back